Login

GENOMIC HEALTH INC 4 SEC Filings

Filed On Filing
14 Nov 2019 Form 4: Fuchs Henry J, Director

Returned 7,833 shares to the issuer · Disposed of 46,583 Director Stock Option (right to buy) (Disposition to Issuer)

14 Nov 2019 Form 4: Parker Geoffrey M., Director

Disposed of 955 shares (Grant/Award Acquisition) · Disposed of 46,583 Director Stock Option (right to buy) (Disposition to Issuer)

14 Nov 2019 Form 4: Cohen Fred E, Director

Returned 75,188 shares to the issuer · Disposed of 46,348 Director Stock Option (right to buy) (Disposition to Issuer)

14 Nov 2019 Form 4: Flannelly Barry P, Director

Returned 397 shares to the issuer · Disposed of 20,000 Director Stock Option (right to buy) (Disposition to Issuer)

14 Nov 2019 Form 4: Graham Ginger L, Director

Returned 53,304 shares to the issuer · Disposed of 74,598 Director Stock Option (right to buy) (Disposition to Issuer)

14 Nov 2019 Form 4: Leber Laura, Chief Communication Officer

Returned 13,736 shares to the issuer · Disposed of 36,470 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 55,920 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

14 Nov 2019 Form 4: McEachron Kim, Chief People Officer

Returned 36,554 shares to the issuer · Disposed of 16,602 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 64,970 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

14 Nov 2019 Form 4: Hoof Torsten, Chief Int'l Commercial Officer

Returned 14,867 shares to the issuer · Disposed of 17,250 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 18,870 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

14 Nov 2019 Form 4: Radford Jason W., Chief Legal Officer

Returned 29,308 shares to the issuer · Disposed of 12,000 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 87,750 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

14 Nov 2019 Form 4: Vaughn James J, Chief Commercial Officer

Returned 16,530 shares to the issuer · Disposed of 107,045 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

14 Nov 2019 Form 4: Pla Frederic, COO

Returned 31,891 shares to the issuer · Disposed of 77,167 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 156,269 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

14 Nov 2019 Form 4: Shak Steven, Chief Scientific Officer

Returned 58,795 shares to the issuer · Disposed of 154,820 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

14 Nov 2019 Form 4: Cole G Bradley, CFO

Returned 39,179 shares to the issuer · Disposed of 21,888 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 252,890 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

14 Nov 2019 Form 4: Popovits Kimberly J, Director

Returned 116,734 shares to the issuer · Disposed of 167,500 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 586,070 Employee Stock Option (right to buy) Holding (Disposition to Issuer)

13 Nov 2019 Form 4: Exact Sciences Corp, 10% owner

Bought 37,643,330 shares

21 Oct 2019 Form 4: Leber Laura, Chief Communication Officer

Gave 275 shares as a gift · Received 13,183 shares by exercise or conversion ($303K) · Sold 13,183 shares ($935K)

09 Oct 2019 Form 4: Vaughn James J, Chief Commercial Officer

Received 4,500 shares by exercise or conversion ($149K) · Sold 4,500 shares ($305K)

09 Oct 2019 Form 4: Popovits Kimberly J, Director

Sold 10,000 shares ($677K)

09 Oct 2019 Form 4: Cole G Bradley, CFO

Received 22,560 shares by exercise or conversion ($696K) · Sold 22,560 shares ($1.56M)

03 Oct 2019 Form 4: Fuchs Henry J, Director

Received 185 shares as a grant or award ($12.4K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support